Anlon Healthcare Limited Delivers Strong Q3 & 9M FY26 Performance; EBITDA Surges 20x, PAT Turns Positive
Rajkot, 10th February 2026 – Anlon Healthcare Limited, a research-driven manufacturer of high-purity pharmaceutical intermediates and APIs, announced its unaudited financial results for Q3 & 9M
